MedPath

Reverse

Brand Name: Reverse

Generic Name: Sugammadex (as sodium)

Active
Registration Number

DRP-13801-01

Dosage Form

Solution for Injection (IV)

Issuance Date

July 31, 2023

Expiry Date

April 27, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength100 mg/mL
PackagingUSP Type I Clear Lyo Bottom Tubular Glass Vial with Grey Chloro Butyl Stopper and White Aluminum Flip-off Seal x 2 mL (Box of 1's)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Antidote
A
Application
CLIDP Conversion
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Sugammadex (as sodium)Active
Monograph: sugammadex (as sodium)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform